Medicine
Tamiflu 6 mg/mL powder for oral suspension
Tamiflu 6 mg/mL powder for oral suspension is a prescription medicine containing Oseltamivir for oral use, marketed by Genentech, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store constituted oral suspension under refrigeration for up to 17 days at 2º…
Key facts
- Active ingredient (INN)
- Oseltamivir
- Brand
- Tamiflu
- Strength
- 6 mg/mL
- Dosage form
- Powder for oral suspension
- Route
- Oral
- Packs
- 1 bottle
- Marketing authorisation holder
- Genentech
- Manufacturer
- Genentech
- Origin register
- US FDA, United States
- Storage
- Store constituted oral suspension under refrigeration for up to 17 days at 2º to 8ºC (36º to 46ºF). Do not freeze. Store the capsules at 25ºC (77ºF), excursions permitted to 15º to 30ºC (59º to 86ºF). Storage Store dry powder at 25ºC (77ºF), excursions permitted to 15º to 30ºC (59º to 86ºF).
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J05AH02 Oseltamivir
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 21 March 2011
- Identifiers
- RxCUI 261315, 312122, 728109 +5DailyMed set ID ee3c9555-60f2-4f82-a760-11983c86e97bNDC 0004-0822Application NDA021246
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle, glass in 1 carton / 60 mL in 1 bottle, glass | 0004-0822-05 | Genentech | 21 March 2011 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Oseltamivir 6 mg/mL powder for oral suspension.
Other strengths and forms of Oseltamivir
Clinical summary
Oseltamivir is a neuraminidase inhibitor indicated for treatment of acute, uncomplicated influenza A and B in patients 2 weeks of age and older who have been symptomatic for no more than 48 hours, among other approved uses. MedsAcross supplies Oseltamivir for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about OseltamivirFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Tamiflu prescribing information (Genentech) · U.S. National Library of Medicine, DailyMed
- Tamiflu: European public assessment report (EPAR) · European Medicines Agency
- Ebilfumin: European public assessment report (EPAR) · European Medicines Agency
Need Tamiflu 6 mg/mL powder for oral suspension for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.